Oral Vaccine Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Vaccine Type (Live vaccine, Inactive Vaccine, Recombinant Vaccine, Others); Application (Polio, Rabies, Tuberculosis, Influenza, Respiratory infections, HIV, Others); End User (Hospitals, Government vaccination programs, Research institutes, Others) and Geography

Report Code: TIPRE00019316 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Vaccination is the efficient and cost effective way to prevent various infectious disorders. The vaccination has prevented the transmission of lethal diseases such as polio, measles across the globe. Oral vaccination has taken immunization process to the next level. Majority of vaccines are given by parenteral route because of instability in gastric environment but for some vaccines the oral route is cost effective and feasible to combat non- mucosal transmitted infections. Oral vaccination has positive patient compliance than parenteral vaccines.

MARKET DYNAMICS

The oral vaccine market is anticipated to grow in the forecast period owing to rising prevalence of infectious disorders and diseases along with efficient and safe nature of oral vaccines. Moreover, resistance issues with existing vaccines and various government initiatives to promote vaccination is also expected to boost market growth. Whereas, first pass metabolism issues with some drugs is the major restraining factor for the market growth.

MARKET SCOPE

The "Oral Vaccine Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Oral Vaccine market with detailed market segmentation by vaccine type, application and end user. The Oral Vaccine Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Oral Vaccine Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Oral Vaccine Market is segmented on the basis of vaccine type, application and end user. On the basis of vaccine type the market is segmented as, live vaccine, inactive vaccine, recombinant vaccine and others. On the basis of application the market is bifurcated as, polio, rabies, TB, influenza, respiratory infections, HIV, others. And on the basis of end user the market is segmented as, hospitals, government vaccination program, research program, others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Oral Vaccine Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Oral Vaccine Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Oral Vaccine Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Oral Vaccine Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Oral Vaccine Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Oral Vaccine Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Oral Vaccine market in the global market. Below mentioned is the list of few companies engaged in the Oral Vaccine Market.

The report also includes the profiles of key players in Oral Vaccine Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Serum Institute of India Pvt. Ltd.
  •   GlaxoSmithKline plc.
  •   Merck and Co. Inc.
  •   Aventis
  •   PaxVax Corporation
  •   VALNEVA Canada, Inc.
  •   Janssen Pharmaceuticals
  •   Shanghai BravoBio Co., Ltd.
  •   Swiss Serum and Vaccine Institute Berne
  •   QUIMICA SUIZA S.A

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Oral Vaccine Market - By Vaccine Type
1.3.2 Oral Vaccine Market - By Application
1.3.3 Oral Vaccine Market - By End User
1.3.4 Oral Vaccine Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ORAL VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ORAL VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ORAL VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. ORAL VACCINE - GLOBAL MARKET OVERVIEW
6.2. ORAL VACCINE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. ORAL VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - VACCINE TYPE
7.1. OVERVIEW
7.2. VACCINE TYPE MARKET FORECASTS AND ANALYSIS
7.3. LIVE VACCINE
7.3.1. Overview
7.3.2. Live vaccine Market Forecast and Analysis
7.4. INACTIVE VACCINE
7.4.1. Overview
7.4.2. Inactive Vaccine Market Forecast and Analysis
7.5. RECOMBINANT VACCINE
7.5.1. Overview
7.5.2. Recombinant Vaccine Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. ORAL VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. POLIO
8.3.1. Overview
8.3.2. Polio Market Forecast and Analysis
8.4. RABIES
8.4.1. Overview
8.4.2. Rabies Market Forecast and Analysis
8.5. TUBERCULOSIS
8.5.1. Overview
8.5.2. Tuberculosis Market Forecast and Analysis
8.6. INFLUENZA
8.6.1. Overview
8.6.2. Influenza Market Forecast and Analysis
8.7. RESPIRATORY INFECTIONS
8.7.1. Overview
8.7.2. Respiratory infections Market Forecast and Analysis
8.8. HIV
8.8.1. Overview
8.8.2. HIV Market Forecast and Analysis
8.9. OTHERS
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis
9. ORAL VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. GOVERNMENT VACCINATION PROGRAMS
9.4.1. Overview
9.4.2. Government vaccination programs Market Forecast and Analysis
9.5. RESEARCH INSTITUTES
9.5.1. Overview
9.5.2. Research institutes Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis

10. ORAL VACCINE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Oral Vaccine Market Overview
10.1.2 North America Oral Vaccine Market Forecasts and Analysis
10.1.3 North America Oral Vaccine Market Forecasts and Analysis - By Vaccine Type
10.1.4 North America Oral Vaccine Market Forecasts and Analysis - By Application
10.1.5 North America Oral Vaccine Market Forecasts and Analysis - By End User
10.1.6 North America Oral Vaccine Market Forecasts and Analysis - By Countries
10.1.6.1 United States Oral Vaccine Market
10.1.6.1.1 United States Oral Vaccine Market by Vaccine Type
10.1.6.1.2 United States Oral Vaccine Market by Application
10.1.6.1.3 United States Oral Vaccine Market by End User
10.1.6.2 Canada Oral Vaccine Market
10.1.6.2.1 Canada Oral Vaccine Market by Vaccine Type
10.1.6.2.2 Canada Oral Vaccine Market by Application
10.1.6.2.3 Canada Oral Vaccine Market by End User
10.1.6.3 Mexico Oral Vaccine Market
10.1.6.3.1 Mexico Oral Vaccine Market by Vaccine Type
10.1.6.3.2 Mexico Oral Vaccine Market by Application
10.1.6.3.3 Mexico Oral Vaccine Market by End User
10.2. EUROPE
10.2.1 Europe Oral Vaccine Market Overview
10.2.2 Europe Oral Vaccine Market Forecasts and Analysis
10.2.3 Europe Oral Vaccine Market Forecasts and Analysis - By Vaccine Type
10.2.4 Europe Oral Vaccine Market Forecasts and Analysis - By Application
10.2.5 Europe Oral Vaccine Market Forecasts and Analysis - By End User
10.2.6 Europe Oral Vaccine Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Oral Vaccine Market
10.2.6.1.1 Germany Oral Vaccine Market by Vaccine Type
10.2.6.1.2 Germany Oral Vaccine Market by Application
10.2.6.1.3 Germany Oral Vaccine Market by End User
10.2.6.2 France Oral Vaccine Market
10.2.6.2.1 France Oral Vaccine Market by Vaccine Type
10.2.6.2.2 France Oral Vaccine Market by Application
10.2.6.2.3 France Oral Vaccine Market by End User
10.2.6.3 Italy Oral Vaccine Market
10.2.6.3.1 Italy Oral Vaccine Market by Vaccine Type
10.2.6.3.2 Italy Oral Vaccine Market by Application
10.2.6.3.3 Italy Oral Vaccine Market by End User
10.2.6.4 Spain Oral Vaccine Market
10.2.6.4.1 Spain Oral Vaccine Market by Vaccine Type
10.2.6.4.2 Spain Oral Vaccine Market by Application
10.2.6.4.3 Spain Oral Vaccine Market by End User
10.2.6.5 United Kingdom Oral Vaccine Market
10.2.6.5.1 United Kingdom Oral Vaccine Market by Vaccine Type
10.2.6.5.2 United Kingdom Oral Vaccine Market by Application
10.2.6.5.3 United Kingdom Oral Vaccine Market by End User
10.2.6.6 Rest of Europe Oral Vaccine Market
10.2.6.6.1 Rest of Europe Oral Vaccine Market by Vaccine Type
10.2.6.6.2 Rest of Europe Oral Vaccine Market by Application
10.2.6.6.3 Rest of Europe Oral Vaccine Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Oral Vaccine Market Overview
10.3.2 Asia-Pacific Oral Vaccine Market Forecasts and Analysis
10.3.3 Asia-Pacific Oral Vaccine Market Forecasts and Analysis - By Vaccine Type
10.3.4 Asia-Pacific Oral Vaccine Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Oral Vaccine Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Oral Vaccine Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Oral Vaccine Market
10.3.6.1.1 Australia Oral Vaccine Market by Vaccine Type
10.3.6.1.2 Australia Oral Vaccine Market by Application
10.3.6.1.3 Australia Oral Vaccine Market by End User
10.3.6.2 China Oral Vaccine Market
10.3.6.2.1 China Oral Vaccine Market by Vaccine Type
10.3.6.2.2 China Oral Vaccine Market by Application
10.3.6.2.3 China Oral Vaccine Market by End User
10.3.6.3 India Oral Vaccine Market
10.3.6.3.1 India Oral Vaccine Market by Vaccine Type
10.3.6.3.2 India Oral Vaccine Market by Application
10.3.6.3.3 India Oral Vaccine Market by End User
10.3.6.4 Japan Oral Vaccine Market
10.3.6.4.1 Japan Oral Vaccine Market by Vaccine Type
10.3.6.4.2 Japan Oral Vaccine Market by Application
10.3.6.4.3 Japan Oral Vaccine Market by End User
10.3.6.5 South Korea Oral Vaccine Market
10.3.6.5.1 South Korea Oral Vaccine Market by Vaccine Type
10.3.6.5.2 South Korea Oral Vaccine Market by Application
10.3.6.5.3 South Korea Oral Vaccine Market by End User
10.3.6.6 Rest of Asia-Pacific Oral Vaccine Market
10.3.6.6.1 Rest of Asia-Pacific Oral Vaccine Market by Vaccine Type
10.3.6.6.2 Rest of Asia-Pacific Oral Vaccine Market by Application
10.3.6.6.3 Rest of Asia-Pacific Oral Vaccine Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Oral Vaccine Market Overview
10.4.2 Middle East and Africa Oral Vaccine Market Forecasts and Analysis
10.4.3 Middle East and Africa Oral Vaccine Market Forecasts and Analysis - By Vaccine Type
10.4.4 Middle East and Africa Oral Vaccine Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Oral Vaccine Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Oral Vaccine Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Oral Vaccine Market
10.4.6.1.1 South Africa Oral Vaccine Market by Vaccine Type
10.4.6.1.2 South Africa Oral Vaccine Market by Application
10.4.6.1.3 South Africa Oral Vaccine Market by End User
10.4.6.2 Saudi Arabia Oral Vaccine Market
10.4.6.2.1 Saudi Arabia Oral Vaccine Market by Vaccine Type
10.4.6.2.2 Saudi Arabia Oral Vaccine Market by Application
10.4.6.2.3 Saudi Arabia Oral Vaccine Market by End User
10.4.6.3 U.A.E Oral Vaccine Market
10.4.6.3.1 U.A.E Oral Vaccine Market by Vaccine Type
10.4.6.3.2 U.A.E Oral Vaccine Market by Application
10.4.6.3.3 U.A.E Oral Vaccine Market by End User
10.4.6.4 Rest of Middle East and Africa Oral Vaccine Market
10.4.6.4.1 Rest of Middle East and Africa Oral Vaccine Market by Vaccine Type
10.4.6.4.2 Rest of Middle East and Africa Oral Vaccine Market by Application
10.4.6.4.3 Rest of Middle East and Africa Oral Vaccine Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Oral Vaccine Market Overview
10.5.2 South and Central America Oral Vaccine Market Forecasts and Analysis
10.5.3 South and Central America Oral Vaccine Market Forecasts and Analysis - By Vaccine Type
10.5.4 South and Central America Oral Vaccine Market Forecasts and Analysis - By Application
10.5.5 South and Central America Oral Vaccine Market Forecasts and Analysis - By End User
10.5.6 South and Central America Oral Vaccine Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Oral Vaccine Market
10.5.6.1.1 Brazil Oral Vaccine Market by Vaccine Type
10.5.6.1.2 Brazil Oral Vaccine Market by Application
10.5.6.1.3 Brazil Oral Vaccine Market by End User
10.5.6.2 Argentina Oral Vaccine Market
10.5.6.2.1 Argentina Oral Vaccine Market by Vaccine Type
10.5.6.2.2 Argentina Oral Vaccine Market by Application
10.5.6.2.3 Argentina Oral Vaccine Market by End User
10.5.6.3 Rest of South and Central America Oral Vaccine Market
10.5.6.3.1 Rest of South and Central America Oral Vaccine Market by Vaccine Type
10.5.6.3.2 Rest of South and Central America Oral Vaccine Market by Application
10.5.6.3.3 Rest of South and Central America Oral Vaccine Market by End User

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. ORAL VACCINE MARKET, KEY COMPANY PROFILES
12.1. SERUM INSTITUTE OF INDIA PVT. LTD
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GLAXOSMITHKLINE PLC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MERCK AND CO. INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. AVENTIS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PAXVAX CORPORATION
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. VALNEVA CANADA INC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JANSSEN PHARMACEUTICALS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SHANGHAI BRAVOBIO CO., LTD
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SWISS SERUM AND VACCINE INSTITUTE BERNE
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. QUÍMICA SUIZA S.A
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1.Serum Institute of India Pvt. Ltd
2.GlaxoSmithKline Plc
3.Merck and Co. Inc
4.Aventis
5.PaxVax Corporation
6.VALNEVA Canada Inc
7.Janssen Pharmaceuticals
8.Shanghai BravoBio Co., Ltd
9.Swiss Serum and Vaccine Institute Berne
10.QUÍMICA SUIZA S.A
TIPRE00019316
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking